Patents by Inventor Suhasini GANTA

Suhasini GANTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10751401
    Abstract: Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial, Ehrlichia and Anaplasma species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0379 and Ech_0230, and their homologs of other related rickettsial pathogens.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: August 25, 2020
    Assignee: Kansas State University Research Foundation
    Inventors: Roman R. Ganta, Chuanmin Cheng, Arathy D. S. Nair, Deborah Jaworski, Suhasini Ganta
  • Publication number: 20200000906
    Abstract: Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial, Ehrlichia and Anaplasma species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0379 and Ech_0230, and their homologs of other related rickettsial pathogens.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 2, 2020
    Inventors: Roman R. Ganta, Chuanmin Cheng, Arathy D. S. Nair, Deborah Jaworski, Suhasini Ganta
  • Patent number: 10434161
    Abstract: Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial, Ehrlichia and Anaplasma species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0660, Ech_0379, and Ech_0230, and their homologs of other related rickettsial pathogens.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: October 8, 2019
    Assignee: Kansas State University Research Foundation
    Inventors: Roman R. Ganta, Chuanmin Cheng, Arathy D. S. Nair, Deborah Jaworski, Suhasini Ganta
  • Publication number: 20180360942
    Abstract: Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial, Ehrlichia and Anaplasma species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0660, Ech_0379, and Ech_0230, and their homologs of other related rickettsial pathogens.
    Type: Application
    Filed: August 21, 2018
    Publication date: December 20, 2018
    Inventors: Roman R. Ganta, Chuanmin Cheng, Arathy D. S. Nair, Deborah Jaworski, Suhasini Ganta
  • Publication number: 20180021421
    Abstract: Attenuated vaccines to protect vertebrate animals and people against tick-born rickettsial, Ehrlichia and Anaplasma species infections is disclosed. Also disclosed are methods to modify the organism to achieve the desired immunity through the modification of a novel genetic region involved in pathogenesis. These compounds represent a needed vaccine against an organism causing life-threatening febrile illness in humans and animals, and also represent the potential to develop new classes of drugs targeting the gene products of genes Ech_0660, Ech_0379, and Ech_0230, and their homologs of other related rickettsial pathogens.
    Type: Application
    Filed: January 19, 2016
    Publication date: January 25, 2018
    Applicant: Kansas State University Research Foundation
    Inventors: Roman R. GANTA, Chuanmin CHENG, Arathy D. S. NAIR, Deborah JAWORSKI, Suhasini GANTA